Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer.

X Pivot; S Wadler; C Kelly; R Ruxer; J Tortochaux; J Stern; D Belpomme; Y Humblet; C Domenge; N Clendeninn

doi:10.1023/a:1013185402896

Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer.

NobleID: NI9P94W72R01S16
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/02412420

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/02412420.svg?ark=w1%2F20260515%2F02412420&value=id)](https://nobleid.org/work/w1/20260515/02412420)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer.

NobleID: NI9P94W72R01S16
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/02412420

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/02412420.svg?ark=w1%2F20260515%2F02412420&value=id)](https://nobleid.org/work/w1/20260515/02412420)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work